Research Letter

Biliary Events and GLP-1 Receptor Agonist Therapy in Adolescents and Young Adults

JAMA Pediatrics 10.1001/jamapediatrics.2026.3918

August 31, 2026 at 11:00 AM EDT

Read the full article

This cohort study explores biliary outcomes associated with use of glucagon-like peptide-1 receptor agonists in youths aged 12 to 21 years with overweight or obesity diagnosis.

Corresponding Author: Josélio Rodrigues de Oliveira Filho, MD, Division of Pediatric Surgery, Mass General Brigham, Harvard Medical School, 55 Fruit St, Warren 11, Boston, MA 02114 (jrodriguesdeoliveira@mgh.harvard.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2026.3918?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=083126

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks